Evonik Invests €52 Million in its Silicone Platform in Essen
Evonik has invested €52 million in the expansion of its silicones platform at its Essen Goldschmidtstraße site in North Rhine-Westphalia.
capacity expansion
BASF Boosts North American Supply of Bio-Based Surfactants With Expansion
Expansion strengthens local supply and supports demand for bio-based and biodegradable surfactants in North America. Complements BASF's global APG production network, including sites in Germany, China and Thailand.
Symrise Expands Production of Musk Fragrances
Symrise is investing in additional global production capacity for Globalide in India and strengthening its ability to supply a sustainable macrocyclic musk fragrance.
Sterling Expands ADC Manufacturing Capacity and Capabilities
Sterling Pharma Solutions has announced completion of an additional, large-scale GMP manufacturing suite at its dedicated bioconjugation facility in the UK, which will double capacity.
PharmaBlock Inaugurates its New OPC R&D Center in Nanjing, China
PharmaBlock Sciences officially inaugurated its new OPC (Oligonucleotides, Peptides, and Conjugates) R&D Center in Nanjing, China.
CordenPharma Invests €80 Million to Expand Sterile Injectable Capacity
CordenPharma is investing €80 million at its Caponago, Italy, site, adding a new facility and fill-finish lines to lift sterile injectable capacity to 500 million units/year, backed by shareholder Astorg.
Northway Biotech Opens €61 Million Cell Therapy and Personalized Medicine CDMO
Northway Biotech is significantly expanding its development and manufacturing capacity with a new 3,500 sq. m facility featuring up to 20 independent cGMP manufacturing lines.
Syensqo Brings Aromatic Compounding Capability to India
Syensqo is investing in a new compounding line for high-performance aromatic polymers at its Panoli site in India, strengthening its ability to serve customers in one of the world's fastest-growing automotive markets.
Eurofins CDMO Alphora Expands Capacity and HPAPI Capabilities
Eurofins CDMO Alphora has expanded its kilolab and high-potency active pharmaceutical ingredient (HPAPI) development and manufacturing capabilities in Ontario.
Evonik Completes Global Methionine Production Overhaul
Fully integrated production in Mobile, Alabama (USA) strengthens supply reliability in the Americas. Completion of backward integration across hubs in Mobile, Antwerp, and Singapore enhances global competitiveness.
Olon Expands Concord, Ohio Site, Doubling US Manufacturing Capacity
Olon has completed a major expansion at its Concord, Ohio facility, doubling production capacity and strengthening the site's role as a US manufacturing hub within its global development network.
Syensqo Expands US Manufacturing Footprint with Maryland Groundbreaking
Syensqo has broken ground on a multi-million-dollar expansion at its Havre de Grace, MD site, boosting capacity by over 30% to meet growing aerospace demand for structural adhesives and surfacing products.
Adragos and Towa to Produce 1.5 Billion Tablets a Year
CDMO Adragos Pharma Kawagoe and Towa Pharmaceutical have agreed to a manufacturing partnership that will nearly triple solid-dosage capacity, shoring up Japan's fragile generics supply chain.
Air Products Completes $70 Million Membrane Facility Expansion
Air Products opened a $70 million expansion of its Missouri Manufacturing and Logistics Center to meet rising demand in biogas, hydrogen, and marine fuel applications.
Siegfried Secures Antitrust Green Light for US and Australia Drug‑Substance Site Takeover
All closing conditions satisfied for the acquisition of three small molecule sites in the US and Australia; closing to occur as of May 1, 2026. Adds highly demanded US-based manufacturing capacity to Siegfried's network.
Cambrex Advances US and European Expansions
Cambrex is advancing its $150 million investment to expand API manufacturing in Iowa and enhance R&D and manufacturing capabilities in Milan, strengthening its services in the US and Europe.
LGM Pharma Boosts US Manufacturing with Additional $9 Million Investment
LGM Pharma invests an additional $9 million to expand US manufacturing, bringing total investment to $15 million across its Texas and Colorado facilities.
Clariant Expands Pharma-Grade PEG Manufacturing into North America
First Clariant facility in the United States to manufacture pharmaceutical-grade polyethylene glycol excipients for oral and topical applications.
CordenPharma Colorado Partners with BioMed Realty on Peptide Development Lab Expansion
Full-building, 15-year lease for 64,000 square feet enables CDMO CordenPharma Colorado to power next-generation peptide development in Boulder, Colorado.
Axplora Invests $60 Million in HPAPI Expansion at Farmabios Site in Italy
$60 million investment to expand highly potent API (HPAPI) development and manufacturing at Axplora’s Farmabios site in Gropello Cairoli, Italy.
Arkema Expands its PVDF Production Capacity in China
Arkema will increase Kynar PVDF production capacity at its Changshu, China site by 20% by 2028 to meet strong demand for batteries, coatings and other high-performance applications in Asia-Pacific and globally.
BASF Opens Expanded Dispersion Production in Durban, Celebrates 60 Years in South Africa
Expansion boosts supply capabilities of dispersions for architectural coatings, construction and paper industries in East, West and Southern Africa.
Cabot Expands Asia-Pacific Production Capabilities for Circular Reinforcing Carbons
Cabot Corporation is establishing new Asia-Pacific production capabilities for circular reinforcing carbons using its Evolve Sustainable Solutions technology platform for more sustainable tire and rubber applications.
Fujifilm Biotechnologies Unveils Biomanufacturing & Process Development UK Expansion
Fujifilm Biotechnologies expanded manufacturing and process development presence in the North East of England to support vital biomanufacturing of innovative medicines and vaccines in the United Kingdom.
Covestro Expands TDI Production Capacity in China
Covestro has completed a major debottlenecking project at its toluene diisocyanate (TDI) production plant in Shanghai, China.
Sharp Services Invests Over €20 Million to Expand Injectables Packaging Capacity
Sharp Services has invested over €20 million to expand injectables packaging capacity at its facilities in Hamont-Achel, Belgium, and Heerenveen, Netherlands, with significant cold chain enhancements.
Aenova Expands Fill & Finish Capacities at its Latina site
Aenova will install an additional filling and manufacturing line at the Latina, Italy, site. This expansion is an important step to meet the increasing global demand for the production of biologics.
Clariant Expands Production Capacities in Daya Bay
Clariant successfully completes its CHF 100 million investment in the Daya Bay plant in China, with the second production line becoming fully operational in November.
Lonza Capsules & Health Ingredients Expands Capsule Manufacturing Capacity in India and China
New capsule manufacturing lines added at Lonza Capsules & Health Ingredients (CHI) facilities in Rewari (IN) and Suzhou (CN), highlighting the long-term strategic commitment to the business and the APAC region.
Nouryon Completes Expansion for Organic Peroxides in China
Dutch specialty chemicals producer Nouryon has completed the capacity expansion for organic peroxides at its manufacturing facility in Ningbo, China. The expansion doubled production capacity to 6,000 tons of organic peroxide products each, which are sold under the Perkadox 14 and Trigonox 101 brands.
Asahi Kasei to Increase Lithium-Ion Battery Separator Coating Capacity
Asahi Kasei will invest in new coating equipment for Hipore lithium-ion battery separators in its US, Japan, and South Korea facilities, starting in the first half of fiscal year 2026. The increased capacity will provide coated separators for batteries powering up to 1.7 million electric vehicles.
AGC Biologics Completes Expansion at Milan Site
AGC Biologics, a biopharma CDMO, has completed the expansion of its manufacturing capacity at the company’s Cell & Gene Center of Excellence in Milan, Italy.
Finnish CDMO Biovian Expands its Facility in Turku
Finnish contract development and manufacturing organization (CDMO) Biovian, specializing in biopharmaceuticals, is investing more than €50 million to expand its manufacturing facility in Turku, Finland.
Braskem Expands its Brazilian Biopolymer Production Plant
Braskem has completed the expansion of production capacity for its biobased ethylene plant in the petrochemical complex of Triunfo, Rio Grande do Sul, Brazil.
CordenPharma Expands at US Site in Colorado
CordenPharma is expanding strategically into synthetic oligonucleotide manufacturing at its plant at Boulder in the US state of Colorado. The two-phase investment is designed to provide innovative biotech and pharma customers with a fully integrated API to Drug Product service offering.
